ModernMedicine Resource Center More Topics

reimbursement trends resource center

Reimbursement hurdles associated with biosimilarsOptimism exists for biosimilars in the United States, but questions regarding FDA approval and reimbursement remain.
Value-based models work: Humana reportHumana’s Medicare Advantage members show better quality, healthier outcomes and lower costs through value-based models.
Five attributes of health plans poised to winToday’s value-focused economy was a primary discussion point at a recent roundtable of health plan CEOs. The discussion led to five essential attributes that organizations must embrace to thrive.
ICD-10 transition: What’s next?Following the ICD-10 transition, real interplay between all stakeholders begins with the patient being the true focus.
Reimbursement lags, legal hurdles slow telemedicine adoptionTelemedicine is gaining broader acceptance, yet legal restrictions and reimbursement barriers continue to slow its momentum.
5 reasons to be concerned over proposed Medicare rule on biosimilar codingA Medicare reimbursement policy proposing that multiple biosimilars have the same pricing J-code for Medicare reimbursement purposes could ultimately result in fewer treatment options, according to a group representing the industry.
Four trends changing the health insurance marketSeveral changes, from new payment models to the "Cadillac Tax," are impacting the health insurance market.
Top 10 risks facing today's healthcare industry: Are you ready?The top ten risks facing healthcare organizations, as collected and analyzed through data by CHAN Healthcare.